Skip to Main Content
CWRU Links

School of
Medicine

National Center for Regenerative Medicine

Research + Clinical Trials

Research + Clinical Trials

The National Center for Regenerative Medicine supports investigators conducting innovative research translating into cell-based therapies and technologies.

NCRM’s comprehensive “bench-to-bedside” approach requires partnering with researchers and institutions to support programs in the areas of:

  • Basic research
  • Clinical research 
  • Biomedical/tissue engineering research

Using stem cells to regenerate new tissue in diseased organs, instead of using drugs or devices, represents a new paradigm in biomedical research. NCRM’s collaborative partnerships have advanced research discoveries and therapeutic uses of stem cells for the following:

  • Cardiovascular disease
  • Adult stem cell transplantation
  • Cancer
  • Genetic disorders
  • Musculoskeletal conditions
  • Neurodegenerative conditions

Our non-embryonic stem investigation uses the following cell types:

  • ASC (adipose stem cells)
  • CSC (cochlear stem cells)
  • CTP (connective tissue progenitors)
  • HSC (hematopoietic stem cells)
  • HB1 (hemangioblast AC133+ cells from umbilical cord blood)
  • MSC (mesenchymal stem cells)
  • MAPC (multipotent adult progenitor cells)
  • NSC (neural stem cells/oligodendrocyte progenitors)
  • SKMB (skeletal myoblasts)
  • UCB (umbilical cord blood derived stem cells)

Access the NCRM Member's Directory.